Search results for "Colorectal cancer"


 
Results 41 - 50 of about 131 for "Colorectal cancer".
Sort by: Relevance | Newest | Oldest

Evaluating risk and screening for colorectal cancer

Fred Ralston Jr., MD, MACP, ACP's immediate past president and a practicing internist in Fayetteville, Tenn., discusses colorectal cancer screening this month at KevinMD.com, one of the Web's leading destinations for provocative physician commentary.
https://immattersacp.org/weekly/archives/2012/03/20/13.htm
20 Mar 2012

Discuss options with patients to increase colorectal cancer screening rates

Yul Ejnes, MD, MACP, continues his monthly column at KevinMD.com, discussing how physicians can increase screening rates for the second leading cause of cancer-related deaths in the U.S.
https://immattersacp.org/weekly/archives/2013/12/17/6.htm
17 Dec 2013

Editor's Note

This issue addressed physician death by suicide, physician mental health and well-being, and early onset colorectal cancer.
https://immattersacp.org/archives/2021/09/editor's-note.htm
1 Sep 2021

Long-term aspirin use may prevent colorectal cancer, analysis shows

The benefit of aspirin on GI tract cancers was seen at a minimum of 6 years of regular use and appeared to be dose-dependent, developing at 0.5 to 1.5 standard (325 mg) aspirin tablets per week.
https://immattersacp.org/weekly/archives/2016/03/15/5.htm
15 Mar 2016

Evidence evolving on aspirin as prevention

Practice-changing points may influence how internists prescribe aspirin for the primary prevention of heart disease.
https://immattersacp.org/archives/2019/03/evidence-evolving-on-aspirin-as-prevention.htm
1 Mar 2019

USPSTF draft recommends daily aspirin to help prevent CVD, colorectal cancer in certain patients

The new recommendations found that current evidence is insufficient to assess the benefits and harms of aspirin use for prevention of these diseases in those younger than 50 years or older than 69 years.
https://immattersacp.org/weekly/archives/2015/09/22/2.htm
22 Sep 2015

Colorectal cancer screening may be cost-effective beyond age 75 in previously unscreened patients, modeling study suggests

Colorectal cancer screening (colonoscopy, sigmoidoscopy, or fecal immunohistochemical testing) may be cost-effective for patients older than 75 who have never been previously screened, according to a new study.
https://immattersacp.org/weekly/archives/2014/06/03/1.htm
3 Jun 2014

High-value management of patients with GI symptoms

Gastroesophageal reflux disease, rectal bleeding, and chronic diarrhea can be controlled better by applying high-value care.
https://immattersacp.org/archives/2017/06/gastro.htm
1 Jun 2017

Latest updates on ACP's priorities, initiatives

ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2020/01/latest-updates-on-acps-priorities-initiatives.htm
1 Jan 2020

Stool DNA testing more sensitive, less specific than FIT

Multitarget stool DNA testing detected significantly more cancer than fecal immunochemical testing (FIT) but had more false-positive results in asymptomatic persons at average risk for colorectal cancer, a study found.
https://immattersacp.org/weekly/archives/2014/03/25/2.htm
25 Mar 2014

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next